Ilika plc Q&A: Launch of Stereax M50 miniature batteries to enable MedTech (LON:IKA)

Ilika Plc

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss the launch of their M50 mm-scale solid state batteries for the MedTech space.

 

Q1: Today, Ilika have announced the launch of its Stereax M50 miniature batteries to enable MedTech. Steve, can you shed a bit more light on these batteries, for example, the dimensions, the capacity and the type of medical devices that could be powered by them?

A1: The M50 measures 10mm by 3mm with a thickness of less than 1mm, they have a capacity of 50 micro-Amp hours which is enough to power small on-the-body sensing devices such as smart contact lenses, dental braces, glucose sensors as well as some implantable devices such as neurostimulators, cardiac rhythm monitors, leadless pacemakers, insulin pumps and blood pressure monitors. Typically, though, the implantable devices require slightly more power and this can be accommodated by stacking several M50’s on top of each other.

 

Q2: If the devices are in the body though, how will they be recharged?

A2: It is possible to do energy harvesting from the movement of the lungs, the beating of the heart and temperature gradients between skin and ambient air but these are still in an early stage of development. So, initially at least, the batteries will be recharged wirelessly by inductive charging using technology that’s already widely available for use in recharging mobile phones.

 

Q3: Do lithium-ion batteries not contain materials that are damaging to the human body?

A3: Like all Ilika’s Stereax batteries, the M50 is based on solid state battery technology which means there’s significantly less risk of leakage which makes it much safer to use than conventional lithium-ion batteries. It’s likely that in a device, the batteries will be packaged inside a small container along with the electronics and these packages will be tested and certified by the device manufacturers to confirm their safety.

 

Q4: What is the benefit of the types of devices powered by the M50 over existing medical devices?

A4: The main benefit is these devices, powered by the M50, will enable more remote patient monitoring rather than getting data from passive devices that require a patient to visit a hospital or clinic on a periodic basis to download data. These active devices will transmit data to a mobile phone and then on to the healthcare professionals who will then be able to provide more proactive patient care.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets.

Ilika takes solid-state battery message to major UK energy storage conference

Ilika will present its UK-developed quasi-solid-state cell technology at the Faraday Institution Conference 2026 in Nottingham, placing its Goliath programme within a major energy storage innovation forum.

Ilika Plc capital raise supports Stereax launch and Goliath progress, says Cavendish

Ilika’s latest Cavendish note highlights fresh funding to support Stereax commercialisation and Goliath development across medical, defence and e-bike markets.

Search